SlideShare uma empresa Scribd logo
1 de 42
Baixar para ler offline
Gauri S. Shrestha, M.Optom, FIACLE
Sujata Rizal, B.Optom Final Year
Prativa Devkota, Final year
Uncorrected refractive error leads to:
Amblyopia
Delayed visual maturation
Deviation of the eyes
1. Is the refractive error within the normal range for the
child’s age?
2. Will this particular child’s refractive error
emmetropise?
3. Will this level of refractive error disrupt normal visual
development or functional vision?
4. Will prescribing spectacles improve visual function or
functional vision?
5. Will prescribing glasses interfere with the normal
process of emmetropisation?
 Knowledge about the normal refractive error of
infants
 Emmetropization process
 The benefits and risks of prescribing spectacles
 Any threat to normal visual development by the
prescription
 Most infants are hyperopic by +2.00 D with SD of 2.0
 In Initial 3 months, controversy over refractive status
to be static or decreasing.
 Average is +2.16 D
 There is rapid decrease in refractive status from
3 months to 12 months.
 The error decrease to 1. 36 D at 9 months
 What happens after ……12 months?
 This is followed by a period of slower change
until two years for hyperopes and four to five
years for myopes
 Few children myopic at birth
 most of those who are either myopic or
 hyperopic will emmetropise.
 The rate of emmetropisation is generally proportional
to the initial error.
◦ those who start off close to emmetropia or with a low
amount of hyperopia show little change
◦ those who have higher ametropia generally show greater
and faster changes
 Higher prevalence of astigmatism at birth but
decrease in degree and magnitude
◦ 69% of children have astigmatism greater than 1.00 D at
birth
 90% Swedish children with astigmatism of +1 or more
was reported to decrease.
Astigmatism of 1 or more
(%)
Age
8-30% 1.2 yrs
4-24% 3-4 yrs
 Higher astigmatism decrease more rapidly in
initial 3-4 years
 Significant WTR, ATR and oblique astigmatism (
least common) are all more common
 all types of astigmatism decrease, with infants
losing approximately two-thirds of their
astigmatism between nine and 21 months (most
common: 1.5- 2 yrs)
 Anisometropia (≥1D) is more common in infants
than adults.
 spherical anisometropia remains more common in
children compared with adults up to four years of
life
 Anisometropia is transient in relatively lower level
of refractive error, for example, 2.50 D or less and
may not lead to amblyopia
 Probability of emmetropisation decreases as
hyperopia increases.
 Probability is < than 50 % for three-month-olds,
who had a cycloplegic spherical equivalent
refraction
greater than 5.00 D.
 Hyperopic children with ATR astigmatism at six
months maintained their hyperopia
(approximately
2.00 D on average)
 Hyperopic children with WTR astigmatism lost
their
hyperopia (ending up at approximately 0.75 D
hyperopic at age six years)
 Main tool to predict emmetropisation is to monitor
the
refraction.
 Those who emmetropise, lose approximately one-
half of their spherical equivalent refractive error in
the first
year and approximately one-third between nine
and 21
months.
 With regards to astigmatism, approximately two-
thirds of the astigmatism is lost between nine and
21 months.
 No way to predict with certainty whether a particular child’s
anisometropia is transient or will remain into adulthood.
 Following things should be taken into account:
 monitor a child over a period of four to six months
 consider VA—if amblyopia is already present it requires
treatment
 higher levels of anisometropia (for example, >3.00 D or more
and particularly 5.00 D or more) are less likely to be transient.
 children with low vision are less likely to fully emmetropise .
 Therefore, these children can be prescribed, with the main
consideration being to optimize visual function.
 Association between lack of emmetropisation and
the presence of strabismus.
 However, its not clear whether strabismus interferes
with emmetropisation or whether those who do not
emmetropise, and thus maintain their higher
hyperopia, are more likely to develop strabismus
 Uncorrected high refractive error (hyperopia,
astigmatism and anisometropia) during the first few
years of life is a risk factor for amblyopia
 There is an increased chance of monocular or
binocular amblyopia in one-year-olds with 3.50 D or
more in one meridian,
 Partial correction of hyperopia greater than 3.50 D
at
nine to 11 months resulted in improved VA at four
years of age and may reduce the incidence of
eso
 In children with 5.00 D or more,
◦ 25 to 43% have acuity of 6/12 or worse
◦ 87 per cent have acuity worse than 6/6.
◦ Poor accommodation and stereopsis
 In the study by Atkinson and colleagues, there
was
no difference in the reduction of hyperopia
comparing
those who were fitted with a partial prescription
and the controls.
 Many authors recommend monitoring the refraction
(hyperopia, myopia or astigmatism) in infants and
toddlers before prescribing.
 Frequently unchanging or increasing refractions
are
associated with amblyopia.
 Only demonstrable amblyopia indicate immediate
prescribing
 The other main factor, which will influence one’s
likelihood of prescribing for hyperopia, is the presence
of heterophoria.
 Correction of hyperopia to optimize alignment
 Prescribing if the refraction is outside the 95% limits for
a particular age.
 Main aim is to bring the uncorrected portion just within
the normal range, for example, to the 95% limit.
 This would leave a large stimulus for emmetropisation
and therefore potentially encourage a greater amount of
emmetropisation
 It seems that the child’s accommodation cannot
overcome the very large uncorrected hyperopia but a
correction that is small enough to bring them just within
the normal range allows them to accommodate for the
remaining hyperopia, resulting in esotropia.
 Thus, when a larger prescription is given, it is imperative to
see the child approximately four to six weeks after the
prescribing appointment
 >3.50 D in one or both meridian
 Atkinson’s protocol based on the plus cylinder
format at this was:
◦ sphere : prescribe 1.0 D less than the least meridian
◦ Cylinder: prescribe half of the astigmatism if
>2.50 D
 < -5.0 D during the first year, reduce by 2.0 D.
Under correct because emmetropisation occurs in
myopia
 In study of Mohindra and Held (1981), refracted 400
children ≤5 yrs using near retinoscopy.
 For children 0 to 4 weeks they found bell shaped
distribution of refractive error ranging from -14 D to
+ 12D gradually narrowing to range of -3 to +4 D at
age of 129 to 256 weeks.
 This demonstrate the process of emmetropization is
evident.
 In a study of 1,432 unselected children, Sorsby,
Benjamin, and sheridan (1961) found the mean
ocular refraction under cycloplegia, decreased
from +2.33D at age 3yrs to 0.93 D at age of 14yrs
in boys and from 2.96D at age 3yrs to 0.64D at
age 15yrs for girls.
 Prevalence of myopia is found to be steadily
increasing during school years.
 In study Blum, Peters, and Bettman found that
prevalence of myopia increased from about 2 % at
age 6 to 15 % at age 15.
 the refraction with higher hyperopia and with
emmetropia remains unchanged
 the refraction with moderate hyperopia still shows
a drift towards emmetropia up to nine or 10 years
of age
 In the school years, myopia should be corrected
for function with full correction
When to consider
prescribing
What to prescribe?
Outside the 95% range
of refraction at any age
according to any
currently available
data. This guideline
could be applied to
other refractive errors
also.
Prescribe so as to leave the uncorrected
hyperopia
somewhat above the mean for the age
3 to 6 months if outside
the 95% range (Partial
correction)
In addition to the level of hyperopia
determined by cycloplegic refraction,
factors that would indicate correction are
VA poorer than 6/100 plus non-
cycloplegic (Mohindra) refraction that is
When to
consider
prescribing
What to prescribe? Comments, rationale
and references
> 3.50 in one or
more meridian at
age of 1 year
upwards
Give partial
prescription
Atkinson’s protocol :
prescribe 1D less than
least hyperopic
meridian
Based on randomised
clinical trials of Atkinson and
colleagues and natural
history study of Ingram and
colleagues
>2.50 at 4 years
upward
Still give partial
correction of hyperopia
Under correct by 1 to
1.50 D*
Based on studies of visual
function and functional
vision and Mayer and co-
worker’s
> 1. 50 D in the
school years
without symptom
Full or near full
correction may be
given at this age, as
emmetropisation has
Studies on visual function
show that hyperopia ranging
from > 1.00 to > 2.00 D may
impact visual function .
When to
consider
prescribing
What to prescribe Comments, rationale and
references
>2.50 D at 15
months of age
upwards
Decrease cylinder by 1.00 D
or give 50%
15 month of period is the most
critical period
> 2. 00 D at 2
years or upward
Give partial cylinder up to 3 to
4 years after which give full
cylinder
Based on finding of better VA in
children whose astigmatism was
corrected at this age and at 2
years approximately 5 to 10%
have astigmatism > 2.00D
> 1.50 D at 4
years upwards
Give full cylinder and in case
of previously uncorrected
high astigmatism, reduced
prescription may be given to
allow child to adapt
Based on studies of Cowen and
Bobier 95th
percentile for
astigmatism was 1.25 in children in
mean age of 4 years
> 1.00 D oblique
astigmatism from
Correct ¾ to the age of 2
and then correct the full
Oblique astigmatism is risk factor
for amblyopia. Mayer and
When to consider
prescribing
What to prescribe Comments, rationale
and references
> 3.00D at 1 year upward Prescribe full anisometropia
if amblyopia is already
present, if there is no
amblyopia reduced
anisometropic correction
could be considered
> 3.00 D of
anisometropia is less
likely to be transient
according to report of
Abrahamsson
> 1.00 D but < 3.00 D after 1
year of age
Monitor for 4 to 6 months
and if persist prescribe
myopia and hyperopia
according to age
Based on report of
transient myopia
> 1.00 D of spherical
hyperopic anisometropia,
≥2.00D of spherical myopic
anisometropia, > 1.50 D of
cylindrical anisometropia after
Prescribe myopia and
hyperopia according to age
This level of amblyopia is
found to be amblyogenic
at this age
When to consider
prescribing
What to prescribe Comments, rationale,
and refrences
< -2 .00D myopia
from one year
Reduce by 0.50 or 1.00 D
until school age
MEPED study showed that <
-1.2 to -1.7 is the lower end
of 95% range in African
American
4 years to early
school years
In correction of low amount of
myopia improves vision ,
correct it. Give full correction
for high amount of myopia
Congdon and colleagues
found the correction of
<0.75 D improved VA.
School age myopia Prescribe full correction. In
cases of myopia with near
esophoria , larger lag of
accomodation or shorter
habitual reading distance,
PAL may be considered
Guideline for bifocal
correction based on the
correction of Myopia
Evaluation Trial Study for 6
to 11 years old
 Overcorrect by 2 to 3.00D because child’s world is
near.
 After 2 to 3 years, distance correction with bifocal
is better option
 Prescription of spectacles thus must be done
keeping factor like emmetropization and
amblyogenic factor in mind.
 Susan J Leat . To prescribe or not to prescribe?
Guidelines for spectacle prescribing in infants and
children. Clin Exp Optom 2011; 94: 6: 514–527.
 Jane Farbrother. Spectacle prescribing in childhood: a survey
of hospital optometrist. Br. J. Ophthalmol.
 SEAN P. DONAHUE. Prescribing Spectacles in Children: A
Pediatric Ophthalmologist’s Approach. Optometry and Vision
Science, Vol. 84, No. 2, February 2007
 Ashwin Sainani. Special considerations for prescription of
glasses in children. Journal of Clinical Ophthalmology and
Research - Sep-Dec 2013 - Volume 1 - Issue 3

Mais conteúdo relacionado

Semelhante a 4.0 guidelines for prescribing glasses in children

paediatric spectacle prescription by optom faslu muhammed
paediatric spectacle prescription by optom faslu muhammedpaediatric spectacle prescription by optom faslu muhammed
paediatric spectacle prescription by optom faslu muhammedOPTOM FASLU MUHAMMED
 
2012 sci-250-guidelines-for-management-of-strabismus-in-childhood-2012
2012 sci-250-guidelines-for-management-of-strabismus-in-childhood-20122012 sci-250-guidelines-for-management-of-strabismus-in-childhood-2012
2012 sci-250-guidelines-for-management-of-strabismus-in-childhood-2012Vinitkumar MJ
 
Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2Alvina Pauline Santiago, MD
 
Basics of pediatric refraction by dr.adnan
 Basics of pediatric refraction by dr.adnan Basics of pediatric refraction by dr.adnan
Basics of pediatric refraction by dr.adnanMahamudAdnan
 
RX for Childhood Hypermetropia
RX for Childhood HypermetropiaRX for Childhood Hypermetropia
RX for Childhood Hypermetropiazolfohashim
 
The Binocular Vision Dysfuction Pandemic
The Binocular Vision Dysfuction PandemicThe Binocular Vision Dysfuction Pandemic
The Binocular Vision Dysfuction PandemicDominick Maino
 
Bridging the gap between ophthalmology & pediatrics 1
Bridging the gap between ophthalmology & pediatrics 1Bridging the gap between ophthalmology & pediatrics 1
Bridging the gap between ophthalmology & pediatrics 1Othman Al-Abbadi
 
Opthalmology for pediatricians
Opthalmology for pediatriciansOpthalmology for pediatricians
Opthalmology for pediatriciansRiyad Banayot
 
Ophthalmology treatment guidelines Govt of India
Ophthalmology treatment guidelines Govt of India Ophthalmology treatment guidelines Govt of India
Ophthalmology treatment guidelines Govt of India Dr Jitu Lal Meena
 
5.0 pediatric refraction
5.0 pediatric refraction5.0 pediatric refraction
5.0 pediatric refractionGauriSShrestha
 
Development Of Vision
Development Of VisionDevelopment Of Vision
Development Of VisionManoj Aryal
 
Spectacles prescription in children
Spectacles  prescription in childrenSpectacles  prescription in children
Spectacles prescription in childrenOmerMonzal
 
myopia new aioc.pptx
myopia new aioc.pptxmyopia new aioc.pptx
myopia new aioc.pptxnehamidha7
 
myopia new aioc.pptx
myopia new aioc.pptxmyopia new aioc.pptx
myopia new aioc.pptxnehamidha7
 
Dr vinit kumar paediatric refraction
Dr vinit kumar  paediatric  refractionDr vinit kumar  paediatric  refraction
Dr vinit kumar paediatric refractionVinitkumar MJ
 

Semelhante a 4.0 guidelines for prescribing glasses in children (20)

Evaluation of squint
Evaluation of squint Evaluation of squint
Evaluation of squint
 
Infant's vision
Infant's visionInfant's vision
Infant's vision
 
paediatric spectacle prescription by optom faslu muhammed
paediatric spectacle prescription by optom faslu muhammedpaediatric spectacle prescription by optom faslu muhammed
paediatric spectacle prescription by optom faslu muhammed
 
2012 sci-250-guidelines-for-management-of-strabismus-in-childhood-2012
2012 sci-250-guidelines-for-management-of-strabismus-in-childhood-20122012 sci-250-guidelines-for-management-of-strabismus-in-childhood-2012
2012 sci-250-guidelines-for-management-of-strabismus-in-childhood-2012
 
Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2
 
Basics of pediatric refraction by dr.adnan
 Basics of pediatric refraction by dr.adnan Basics of pediatric refraction by dr.adnan
Basics of pediatric refraction by dr.adnan
 
RX for Childhood Hypermetropia
RX for Childhood HypermetropiaRX for Childhood Hypermetropia
RX for Childhood Hypermetropia
 
The Binocular Vision Dysfuction Pandemic
The Binocular Vision Dysfuction PandemicThe Binocular Vision Dysfuction Pandemic
The Binocular Vision Dysfuction Pandemic
 
Bridging the gap between ophthalmology & pediatrics 1
Bridging the gap between ophthalmology & pediatrics 1Bridging the gap between ophthalmology & pediatrics 1
Bridging the gap between ophthalmology & pediatrics 1
 
Hypeopia
HypeopiaHypeopia
Hypeopia
 
Opthalmology for pediatricians
Opthalmology for pediatriciansOpthalmology for pediatricians
Opthalmology for pediatricians
 
Strabismus stdents 2
Strabismus stdents 2Strabismus stdents 2
Strabismus stdents 2
 
Ophthalmology treatment guidelines Govt of India
Ophthalmology treatment guidelines Govt of India Ophthalmology treatment guidelines Govt of India
Ophthalmology treatment guidelines Govt of India
 
5.0 pediatric refraction
5.0 pediatric refraction5.0 pediatric refraction
5.0 pediatric refraction
 
Glass prescription in children
Glass prescription in childrenGlass prescription in children
Glass prescription in children
 
Development Of Vision
Development Of VisionDevelopment Of Vision
Development Of Vision
 
Spectacles prescription in children
Spectacles  prescription in childrenSpectacles  prescription in children
Spectacles prescription in children
 
myopia new aioc.pptx
myopia new aioc.pptxmyopia new aioc.pptx
myopia new aioc.pptx
 
myopia new aioc.pptx
myopia new aioc.pptxmyopia new aioc.pptx
myopia new aioc.pptx
 
Dr vinit kumar paediatric refraction
Dr vinit kumar  paediatric  refractionDr vinit kumar  paediatric  refraction
Dr vinit kumar paediatric refraction
 

Mais de GauriSShrestha

artificial tears and viscoelastic eye medicines
artificial tears and viscoelastic eye medicinesartificial tears and viscoelastic eye medicines
artificial tears and viscoelastic eye medicinesGauriSShrestha
 
Vital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptxVital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptxGauriSShrestha
 
Local Ocular Anesthetics Used in Ophthalmic Clinics
Local Ocular Anesthetics Used in Ophthalmic ClinicsLocal Ocular Anesthetics Used in Ophthalmic Clinics
Local Ocular Anesthetics Used in Ophthalmic ClinicsGauriSShrestha
 
Ocular Antihistamines and Anti-allergics
Ocular Antihistamines and Anti-allergicsOcular Antihistamines and Anti-allergics
Ocular Antihistamines and Anti-allergicsGauriSShrestha
 
Miotics, Mydriatics, Cycloplegics Used in Ophthalmic Practice
Miotics, Mydriatics, Cycloplegics Used in Ophthalmic PracticeMiotics, Mydriatics, Cycloplegics Used in Ophthalmic Practice
Miotics, Mydriatics, Cycloplegics Used in Ophthalmic PracticeGauriSShrestha
 
Medicines Used for Glaucoma Management _Optom Lecture
Medicines Used for Glaucoma Management _Optom LectureMedicines Used for Glaucoma Management _Optom Lecture
Medicines Used for Glaucoma Management _Optom LectureGauriSShrestha
 
Ocular steroids-Dexamethasone, Betamethasone, Prednisolone and Flurometholone
Ocular steroids-Dexamethasone, Betamethasone, Prednisolone and FlurometholoneOcular steroids-Dexamethasone, Betamethasone, Prednisolone and Flurometholone
Ocular steroids-Dexamethasone, Betamethasone, Prednisolone and FlurometholoneGauriSShrestha
 
Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)
Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)
Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)GauriSShrestha
 
Ocular anti-infective agents: Antibiotics, Antivirals and antifungals
Ocular anti-infective agents: Antibiotics, Antivirals and antifungalsOcular anti-infective agents: Antibiotics, Antivirals and antifungals
Ocular anti-infective agents: Antibiotics, Antivirals and antifungalsGauriSShrestha
 
2.0 convergence insufficiency b
2.0 convergence insufficiency b2.0 convergence insufficiency b
2.0 convergence insufficiency bGauriSShrestha
 
Sensory evaluation of strabismus
Sensory evaluation of strabismusSensory evaluation of strabismus
Sensory evaluation of strabismusGauriSShrestha
 
Sensory evaluation of strabismus
Sensory evaluation of strabismusSensory evaluation of strabismus
Sensory evaluation of strabismusGauriSShrestha
 
Motor evaluation of strabismus
Motor evaluation of strabismusMotor evaluation of strabismus
Motor evaluation of strabismusGauriSShrestha
 
Accomodative insufficiency s
Accomodative insufficiency sAccomodative insufficiency s
Accomodative insufficiency sGauriSShrestha
 
Objective, subjective and cyclopegic refraction
Objective, subjective and cyclopegic refractionObjective, subjective and cyclopegic refraction
Objective, subjective and cyclopegic refractionGauriSShrestha
 

Mais de GauriSShrestha (20)

artificial tears and viscoelastic eye medicines
artificial tears and viscoelastic eye medicinesartificial tears and viscoelastic eye medicines
artificial tears and viscoelastic eye medicines
 
Vital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptxVital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptx
 
Local Ocular Anesthetics Used in Ophthalmic Clinics
Local Ocular Anesthetics Used in Ophthalmic ClinicsLocal Ocular Anesthetics Used in Ophthalmic Clinics
Local Ocular Anesthetics Used in Ophthalmic Clinics
 
Ocular Antihistamines and Anti-allergics
Ocular Antihistamines and Anti-allergicsOcular Antihistamines and Anti-allergics
Ocular Antihistamines and Anti-allergics
 
Miotics, Mydriatics, Cycloplegics Used in Ophthalmic Practice
Miotics, Mydriatics, Cycloplegics Used in Ophthalmic PracticeMiotics, Mydriatics, Cycloplegics Used in Ophthalmic Practice
Miotics, Mydriatics, Cycloplegics Used in Ophthalmic Practice
 
Medicines Used for Glaucoma Management _Optom Lecture
Medicines Used for Glaucoma Management _Optom LectureMedicines Used for Glaucoma Management _Optom Lecture
Medicines Used for Glaucoma Management _Optom Lecture
 
Ocular steroids-Dexamethasone, Betamethasone, Prednisolone and Flurometholone
Ocular steroids-Dexamethasone, Betamethasone, Prednisolone and FlurometholoneOcular steroids-Dexamethasone, Betamethasone, Prednisolone and Flurometholone
Ocular steroids-Dexamethasone, Betamethasone, Prednisolone and Flurometholone
 
Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)
Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)
Ocular NSAIDs (Non-steroidal Anti-inflammatory Drugs)
 
Ocular anti-infective agents: Antibiotics, Antivirals and antifungals
Ocular anti-infective agents: Antibiotics, Antivirals and antifungalsOcular anti-infective agents: Antibiotics, Antivirals and antifungals
Ocular anti-infective agents: Antibiotics, Antivirals and antifungals
 
Optometry profession
Optometry  professionOptometry  profession
Optometry profession
 
2.0 convergence insufficiency b
2.0 convergence insufficiency b2.0 convergence insufficiency b
2.0 convergence insufficiency b
 
Presbyopia
PresbyopiaPresbyopia
Presbyopia
 
Sensory evaluation of strabismus
Sensory evaluation of strabismusSensory evaluation of strabismus
Sensory evaluation of strabismus
 
Sensory evaluation of strabismus
Sensory evaluation of strabismusSensory evaluation of strabismus
Sensory evaluation of strabismus
 
Motor evaluation of strabismus
Motor evaluation of strabismusMotor evaluation of strabismus
Motor evaluation of strabismus
 
Accomodative insufficiency s
Accomodative insufficiency sAccomodative insufficiency s
Accomodative insufficiency s
 
Refraction simplified
Refraction simplifiedRefraction simplified
Refraction simplified
 
Aniseikonia
AniseikoniaAniseikonia
Aniseikonia
 
Objective, subjective and cyclopegic refraction
Objective, subjective and cyclopegic refractionObjective, subjective and cyclopegic refraction
Objective, subjective and cyclopegic refraction
 
Depth perception
Depth perceptionDepth perception
Depth perception
 

4.0 guidelines for prescribing glasses in children

  • 1. Gauri S. Shrestha, M.Optom, FIACLE Sujata Rizal, B.Optom Final Year Prativa Devkota, Final year
  • 2. Uncorrected refractive error leads to: Amblyopia Delayed visual maturation Deviation of the eyes
  • 3. 1. Is the refractive error within the normal range for the child’s age? 2. Will this particular child’s refractive error emmetropise? 3. Will this level of refractive error disrupt normal visual development or functional vision? 4. Will prescribing spectacles improve visual function or functional vision? 5. Will prescribing glasses interfere with the normal process of emmetropisation?
  • 4.  Knowledge about the normal refractive error of infants  Emmetropization process  The benefits and risks of prescribing spectacles  Any threat to normal visual development by the prescription
  • 5.  Most infants are hyperopic by +2.00 D with SD of 2.0  In Initial 3 months, controversy over refractive status to be static or decreasing.  Average is +2.16 D
  • 6.  There is rapid decrease in refractive status from 3 months to 12 months.  The error decrease to 1. 36 D at 9 months  What happens after ……12 months?  This is followed by a period of slower change until two years for hyperopes and four to five years for myopes
  • 7.  Few children myopic at birth  most of those who are either myopic or  hyperopic will emmetropise.  The rate of emmetropisation is generally proportional to the initial error. ◦ those who start off close to emmetropia or with a low amount of hyperopia show little change ◦ those who have higher ametropia generally show greater and faster changes
  • 8.  Higher prevalence of astigmatism at birth but decrease in degree and magnitude ◦ 69% of children have astigmatism greater than 1.00 D at birth  90% Swedish children with astigmatism of +1 or more was reported to decrease. Astigmatism of 1 or more (%) Age 8-30% 1.2 yrs 4-24% 3-4 yrs
  • 9.  Higher astigmatism decrease more rapidly in initial 3-4 years  Significant WTR, ATR and oblique astigmatism ( least common) are all more common  all types of astigmatism decrease, with infants losing approximately two-thirds of their astigmatism between nine and 21 months (most common: 1.5- 2 yrs)
  • 10.  Anisometropia (≥1D) is more common in infants than adults.  spherical anisometropia remains more common in children compared with adults up to four years of life  Anisometropia is transient in relatively lower level of refractive error, for example, 2.50 D or less and may not lead to amblyopia
  • 11.  Probability of emmetropisation decreases as hyperopia increases.  Probability is < than 50 % for three-month-olds, who had a cycloplegic spherical equivalent refraction greater than 5.00 D.
  • 12.  Hyperopic children with ATR astigmatism at six months maintained their hyperopia (approximately 2.00 D on average)  Hyperopic children with WTR astigmatism lost their hyperopia (ending up at approximately 0.75 D hyperopic at age six years)
  • 13.  Main tool to predict emmetropisation is to monitor the refraction.  Those who emmetropise, lose approximately one- half of their spherical equivalent refractive error in the first year and approximately one-third between nine and 21 months.  With regards to astigmatism, approximately two- thirds of the astigmatism is lost between nine and 21 months.
  • 14.  No way to predict with certainty whether a particular child’s anisometropia is transient or will remain into adulthood.  Following things should be taken into account:  monitor a child over a period of four to six months  consider VA—if amblyopia is already present it requires treatment  higher levels of anisometropia (for example, >3.00 D or more and particularly 5.00 D or more) are less likely to be transient.  children with low vision are less likely to fully emmetropise .  Therefore, these children can be prescribed, with the main consideration being to optimize visual function.
  • 15.  Association between lack of emmetropisation and the presence of strabismus.  However, its not clear whether strabismus interferes with emmetropisation or whether those who do not emmetropise, and thus maintain their higher hyperopia, are more likely to develop strabismus
  • 16.  Uncorrected high refractive error (hyperopia, astigmatism and anisometropia) during the first few years of life is a risk factor for amblyopia  There is an increased chance of monocular or binocular amblyopia in one-year-olds with 3.50 D or more in one meridian,
  • 17.  Partial correction of hyperopia greater than 3.50 D at nine to 11 months resulted in improved VA at four years of age and may reduce the incidence of eso  In children with 5.00 D or more, ◦ 25 to 43% have acuity of 6/12 or worse ◦ 87 per cent have acuity worse than 6/6. ◦ Poor accommodation and stereopsis
  • 18.  In the study by Atkinson and colleagues, there was no difference in the reduction of hyperopia comparing those who were fitted with a partial prescription and the controls.
  • 19.  Many authors recommend monitoring the refraction (hyperopia, myopia or astigmatism) in infants and toddlers before prescribing.  Frequently unchanging or increasing refractions are associated with amblyopia.
  • 20.  Only demonstrable amblyopia indicate immediate prescribing  The other main factor, which will influence one’s likelihood of prescribing for hyperopia, is the presence of heterophoria.  Correction of hyperopia to optimize alignment
  • 21.  Prescribing if the refraction is outside the 95% limits for a particular age.  Main aim is to bring the uncorrected portion just within the normal range, for example, to the 95% limit.  This would leave a large stimulus for emmetropisation and therefore potentially encourage a greater amount of emmetropisation
  • 22.  It seems that the child’s accommodation cannot overcome the very large uncorrected hyperopia but a correction that is small enough to bring them just within the normal range allows them to accommodate for the remaining hyperopia, resulting in esotropia.  Thus, when a larger prescription is given, it is imperative to see the child approximately four to six weeks after the prescribing appointment
  • 23.  >3.50 D in one or both meridian  Atkinson’s protocol based on the plus cylinder format at this was: ◦ sphere : prescribe 1.0 D less than the least meridian ◦ Cylinder: prescribe half of the astigmatism if >2.50 D
  • 24.  < -5.0 D during the first year, reduce by 2.0 D. Under correct because emmetropisation occurs in myopia
  • 25.
  • 26.  In study of Mohindra and Held (1981), refracted 400 children ≤5 yrs using near retinoscopy.  For children 0 to 4 weeks they found bell shaped distribution of refractive error ranging from -14 D to + 12D gradually narrowing to range of -3 to +4 D at age of 129 to 256 weeks.  This demonstrate the process of emmetropization is evident.
  • 27.  In a study of 1,432 unselected children, Sorsby, Benjamin, and sheridan (1961) found the mean ocular refraction under cycloplegia, decreased from +2.33D at age 3yrs to 0.93 D at age of 14yrs in boys and from 2.96D at age 3yrs to 0.64D at age 15yrs for girls.
  • 28.  Prevalence of myopia is found to be steadily increasing during school years.  In study Blum, Peters, and Bettman found that prevalence of myopia increased from about 2 % at age 6 to 15 % at age 15.
  • 29.
  • 30.
  • 31.  the refraction with higher hyperopia and with emmetropia remains unchanged  the refraction with moderate hyperopia still shows a drift towards emmetropia up to nine or 10 years of age  In the school years, myopia should be corrected for function with full correction
  • 32. When to consider prescribing What to prescribe? Outside the 95% range of refraction at any age according to any currently available data. This guideline could be applied to other refractive errors also. Prescribe so as to leave the uncorrected hyperopia somewhat above the mean for the age 3 to 6 months if outside the 95% range (Partial correction) In addition to the level of hyperopia determined by cycloplegic refraction, factors that would indicate correction are VA poorer than 6/100 plus non- cycloplegic (Mohindra) refraction that is
  • 33. When to consider prescribing What to prescribe? Comments, rationale and references > 3.50 in one or more meridian at age of 1 year upwards Give partial prescription Atkinson’s protocol : prescribe 1D less than least hyperopic meridian Based on randomised clinical trials of Atkinson and colleagues and natural history study of Ingram and colleagues >2.50 at 4 years upward Still give partial correction of hyperopia Under correct by 1 to 1.50 D* Based on studies of visual function and functional vision and Mayer and co- worker’s > 1. 50 D in the school years without symptom Full or near full correction may be given at this age, as emmetropisation has Studies on visual function show that hyperopia ranging from > 1.00 to > 2.00 D may impact visual function .
  • 34. When to consider prescribing What to prescribe Comments, rationale and references >2.50 D at 15 months of age upwards Decrease cylinder by 1.00 D or give 50% 15 month of period is the most critical period > 2. 00 D at 2 years or upward Give partial cylinder up to 3 to 4 years after which give full cylinder Based on finding of better VA in children whose astigmatism was corrected at this age and at 2 years approximately 5 to 10% have astigmatism > 2.00D > 1.50 D at 4 years upwards Give full cylinder and in case of previously uncorrected high astigmatism, reduced prescription may be given to allow child to adapt Based on studies of Cowen and Bobier 95th percentile for astigmatism was 1.25 in children in mean age of 4 years > 1.00 D oblique astigmatism from Correct ¾ to the age of 2 and then correct the full Oblique astigmatism is risk factor for amblyopia. Mayer and
  • 35. When to consider prescribing What to prescribe Comments, rationale and references > 3.00D at 1 year upward Prescribe full anisometropia if amblyopia is already present, if there is no amblyopia reduced anisometropic correction could be considered > 3.00 D of anisometropia is less likely to be transient according to report of Abrahamsson > 1.00 D but < 3.00 D after 1 year of age Monitor for 4 to 6 months and if persist prescribe myopia and hyperopia according to age Based on report of transient myopia > 1.00 D of spherical hyperopic anisometropia, ≥2.00D of spherical myopic anisometropia, > 1.50 D of cylindrical anisometropia after Prescribe myopia and hyperopia according to age This level of amblyopia is found to be amblyogenic at this age
  • 36. When to consider prescribing What to prescribe Comments, rationale, and refrences < -2 .00D myopia from one year Reduce by 0.50 or 1.00 D until school age MEPED study showed that < -1.2 to -1.7 is the lower end of 95% range in African American 4 years to early school years In correction of low amount of myopia improves vision , correct it. Give full correction for high amount of myopia Congdon and colleagues found the correction of <0.75 D improved VA. School age myopia Prescribe full correction. In cases of myopia with near esophoria , larger lag of accomodation or shorter habitual reading distance, PAL may be considered Guideline for bifocal correction based on the correction of Myopia Evaluation Trial Study for 6 to 11 years old
  • 37.  Overcorrect by 2 to 3.00D because child’s world is near.  After 2 to 3 years, distance correction with bifocal is better option
  • 38.
  • 39.
  • 40.
  • 41.  Prescription of spectacles thus must be done keeping factor like emmetropization and amblyogenic factor in mind.
  • 42.  Susan J Leat . To prescribe or not to prescribe? Guidelines for spectacle prescribing in infants and children. Clin Exp Optom 2011; 94: 6: 514–527.  Jane Farbrother. Spectacle prescribing in childhood: a survey of hospital optometrist. Br. J. Ophthalmol.  SEAN P. DONAHUE. Prescribing Spectacles in Children: A Pediatric Ophthalmologist’s Approach. Optometry and Vision Science, Vol. 84, No. 2, February 2007  Ashwin Sainani. Special considerations for prescription of glasses in children. Journal of Clinical Ophthalmology and Research - Sep-Dec 2013 - Volume 1 - Issue 3